Aurora Kinase
Aurora Kinase(极光激酶)
Aurora kinases are a family of serine-threonine kinases of three highly homologous members, including aurora A kinase, aurora B kinase and aurora C kinase, which are responsible for chromosome assembly and segregation during mitosis. Aurora kinases are characterized by two domains: a regulatory domain in the NH2 terminus and a catalytic domain in the COOH terminus, in which an A-Box and a D-Box found correspondingly in each domain are responsible for protein degradation. Aurora A kinase plays an important role in centrosome function and duplication, mitotic entry and bipolar spindle assembly; while Aurora B kinase is the catalytic component of the chromosomal passenger complex regulating the accurate segregation of the chromatids at mitosis, histone modification and cytokinesis. Aurora C kinase is less studied and expressed restrictedly in the testes.
Aurora Kinase 相关产品(57)
- GC68147dAURK-4 hydrochloride
dAURK-4 hydrochloride 是 Alisertib 的一种衍生物,是一种有效的选择性 AURKA (Aurora A) 降解剂。dAURK-4 hydrochloride 具有抗癌作用。
- GC69068ENMD-2076 TartrateCAS: 1453868-32-0纯度: >99.00%
ENMD-2076 Tartrate 是多靶点激酶抑制剂,抑制 Aurora A,Flt3,KDR/VEGFR2,Flt4/VEGFR3,FGFR1,FGFR2,Src,PDGFRα 的IC50 值分别为1.86,14,58.2,15.9,92.7,70.8,20.2 and 56.4 nM。
- GC70030TinengotinibCAS: 2230490-29-4
Tinengotinib 是一种或多种蛋白激酶的调节剂,例如 Aurora 激酶和 VEGFR 激酶。Tinengotinib 具有研究这些激酶异常介导的疾病的潜力,尤其是癌症相关疾病 (摘自专利 WO2018108079A1)。
- GC73375Aurora Kinases-IN-3CAS: 2840558-83-8纯度: >98.00%
Aurora Kinases-IN-3(化合物15a)是一种口服活性AURKB抑制剂,通过破坏AURKB的有丝分裂定位来引发AURKB抑制活性。
- GC73753EGFR/AURKB-IN-1CAS: 3008543-34-5纯度: 不显示
EGFR/AURKB-IN-1(化合物7)是双靶向EGFR/AURKB抑制剂,抑制L858R EGFR和AURKB的磷酸化,ic50值分别为0.07和1.1。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC68147 | dAURK-4 hydrochloride | - | - | |
dAURK-4 hydrochloride 是 Alisertib 的一种衍生物,是一种有效的选择性 AURKA (Aurora A) 降解剂。dAURK-4 hydrochloride 具有抗癌作用。 | ||||
| GC69068 | ENMD-2076 Tartrate | 1453868-32-0 | >99.00% | |
ENMD-2076 Tartrate 是多靶点激酶抑制剂,抑制 Aurora A,Flt3,KDR/VEGFR2,Flt4/VEGFR3,FGFR1,FGFR2,Src,PDGFRα 的IC50 值分别为1.86,14,58.2,15.9,92.7,70.8,20.2 and 56.4 nM。 | ||||
| GC70030 | Tinengotinib | 2230490-29-4 | - | |
Tinengotinib 是一种或多种蛋白激酶的调节剂,例如 Aurora 激酶和 VEGFR 激酶。Tinengotinib 具有研究这些激酶异常介导的疾病的潜力,尤其是癌症相关疾病 (摘自专利 WO2018108079A1)。 | ||||
| GC72964 | Aurkin A | 1534060-58-6 | >98.00% | |
Aurkin A是极光A激酶(Aurora A Kinase,也称Aurka)与TPX2相互作用的变抗抑制剂,通过靶向TPX2结合位点,Kd为3.77 μM。 | ||||
| GC73375 | Aurora Kinases-IN-3 | 2840558-83-8 | >98.00% | |
Aurora Kinases-IN-3(化合物15a)是一种口服活性AURKB抑制剂,通过破坏AURKB的有丝分裂定位来引发AURKB抑制活性。 | ||||
| GC73744 | JAB-2485 | 2899209-55-1 | >98.00% | |
JAB-2485是一种有效的选择性极光激酶a (AURKA)抑制剂,IC50为0.33 nM。 | ||||
| GC73753 | EGFR/AURKB-IN-1 | 3008543-34-5 | 不显示 | |
EGFR/AURKB-IN-1(化合物7)是双靶向EGFR/AURKB抑制剂,抑制L858R EGFR和AURKB的磷酸化,ic50值分别为0.07和1.1。 | ||||
| GC74000 | DBPR728 | 2702965-64-6 | >98.00% | |
DBPR728是6K465的酰基前药,携带较少的氢键供体。 | ||||
| GC10442 | MK-8745 | 885325-71-3 | >99.00% | |
An Aurora A kinase inhibitor | ||||
